Neumora Therapeutics, Inc. NMRA
0.50 USD +0.02 (+3.35%)
At closeNov 6, 2026, 6:12 PM EST
0.52 +0.02 +3.32%
After hours · Nov 6, 6:12 PM ET
0.4703 Day range 0.5699
0.315 52-week range 3.65
- YTD
- -71.88%
- 1 year
- -80.49%
Analyst view
Consensus: buy
Buy
Price target (mean) 11.77 +2237.9% upside
Now 0.5033
- Target (low)
- 4.00
- Target (mean)
- 11.77
- Target (high)
- 30.00
Ratings (0m) 9 7 buy · 2 hold · 0 sell
- Strong buy2
- Buy5
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
- 2 months ago 9
- 3 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.44226 | -0.47355 – -0.40 | -0.71 | +37.7% | 0 | 0.0% | 6 |
| Next quarter | -0.4375 | -0.47 – -0.39 | -0.34 | -28.7% | 0 | 0.0% | 4 |
| Current year | -1.60 | -1.63 – -1.52 | -3.63 | +56.0% | 0 | 0.0% | 7 |
| Next year | -1.55 | -1.94 – -1.11 | -1.60 | +2.8% | 0 | 0.0% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 14, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 6, 2025 | B of A Securities | Maintained | Buy | Buy |
| Jan 3, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 2, 2025 | Needham | Reiterated | Buy | Buy |
| Dec 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 22, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Nov 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 13, 2024 | Needham | Reiterated | Buy | Buy |
| Nov 5, 2024 | JP Morgan | Downgrade | Overweight | Neutral |
| Oct 18, 2024 | Needham | Reiterated | Buy | Buy |
| Oct 1, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Sep 12, 2024 | Needham | Reiterated | Buy | Buy |
| Sep 4, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 7, 2024 | Needham | Reiterated | Buy | Buy |
| Jul 22, 2024 | Needham | Initiated | — | Buy |
| Jul 8, 2024 | Mizuho | Initiated | — | Outperform |
| Mar 28, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Mar 18, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 8, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 8, 2023 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 10, 2023 | JP Morgan | Initiated | — | Overweight |
| Oct 10, 2023 | B of A Securities | Initiated | — | Buy |
| Oct 10, 2023 | William Blair | Initiated | — | Outperform |
| Oct 10, 2023 | Guggenheim | Initiated | — | Buy |
| Oct 10, 2023 | RBC Capital | Initiated | — | Outperform |
| Oct 10, 2023 | Stifel | Initiated | — | Buy |